Clinical Trial Update: Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 trial assessing topical tranexamic acid and bacitracin in dialysis patients with arteriovenous fistula has completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriovenous Fistula

Drugs mentioned

• Bacitracin (bacitracin)
• Topical tranexamic acid (tranexamic acid)

Snippet

Sponsor: California Institute of Renal Research | Conditions: Arteriovenous Fistula | Phase 4 | Status: COMPLETED | Results posted: 2017-09-25